Qynapse
Medical Equipment ManufacturingÎle-de-France, France11-50 Employees
Qynapse is a medical device company focused on neuroimaging analysis that supports clinicians, patients, payers, and pharmaceutical researchers by providing reliable, objective measures from MRI scans. Its flagship platform, QyScore, is FDA-cleared and CE-marked and leverages proprietary artificial intelligence to enhance the accuracy and consistency of readings for central nervous system disorders, including Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. The company also develops QyPredict, a research-use-only platform designed to model disease trajectories and potentially improve patient selection and trial design in CNS research. Headquartered in Paris with additional operations in the United States and Canada, Qynapse collaborates with scientific and clinical partners to advance neuroimaging solutions. Its target market includes clinicians, researchers, payers, and pharma, and the company positions itself within the medical equipment manufacturing sector by delivering imaging analysis tools that aim to increase diagnostic precision and support clinical development in CNS conditions. A recent public focus includes participation in major European radiology and neuroradiology conferences, signaling ongoing engagement with the wider neuroimaging community.
1-888-653-2347 
support@leadiq.com 
